Condition: Tachyarrhythmia · Heart Failure · Sponsor: Biotronik SE & Co. KG
The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock\_BC (Ilivia Neo, Intica Neo) implant and programmer software features. The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky). The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.
This description comes directly from the study's public registry record.
Anja Viehrig, Dr. rer. nat. · +49(0)1516890-1304 · anja.viehrig@biotronik.com
Konstantinia Skreka, Dr. rer. nat. · 030-68905 2949 · konstantinia.skreka@biotronik.com
Always discuss trial participation with your own doctor first.
| Medizinische Universität Graz | Graz, Styria, Austria | Recruiting |
| Fakultní nemocnice u sv. Anny v Brně | Brno, Czechia | Recruiting |
| Nemocnice Ceske Budejovice, a.s. | České Budějovice, Czechia | Recruiting |
| Universitätsklinikum Würzburg | Würzburg, Bavaria, Germany | Recruiting |
| SRH Wald-Klinikum Gera GmbH | Gera, Thuringia, Germany | Recruiting |
| Semmelweis University | Budapest, Hungary | Recruiting |
| University of Pécs | Pécs, Hungary | Recruiting |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07360158